Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients

被引：0
|
作者：
Ennio Lubrano
Fabio Massimo Perrotta
Silvia Scriffignano
Laura C. Coates
Philip Helliwell
机构：
[1] Università degli Studi del Molise,Dipartimento di Medicina e Scienze, della Salute “Vincenzo Tiberio”
[2] University of Oxford,Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
[3] University of Leeds,Leeds Institute of Rheumatic and Musculoskeletal Medicine
来源：
Rheumatology and Therapy | 2019年 / 6卷
关键词：
Psoriatic arthritis; Remission; Very low disease activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：521 / 528
页数：7
相关论文
共 50 条
  • [31] PROBABILITY OF ACHIEVING LOW DISEASE ACTIVITY OR REMISSION IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH APREMILAST
    Mease, Philip J.
    Behrens, Frank
    Gladman, Dafna D.
    Kavanaugh, Arthur
    Brunori, Michele
    Teng, Lichen
    Guerette, Benoit
    Queiro, Ruben
    Ogdie, Alexis
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 916 - 917
  • [32] What influences patients' opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international study
    Coates, Laura C.
    Robinson, Danielle E.
    Orbai, Ana-Maria
    Kiltz, Uta
    Leung, Ying-Ying
    Palominos, Penelope
    Canete, Juan D.
    Scrivo, Rossana
    Balanescu, Andra
    Dernis, Emmanuelle
    Meisalu, Sandra
    Ruyssen-Witrand, Adeline
    Eder, Lihi
    de Wit, Maarten
    Smolen, Josef S.
    Lubrano, Ennio
    Gossec, Laure
    RHEUMATOLOGY, 2021, 60 (11) : 5292 - 5299
  • [33] What Influences Patients' Opinion of Remission and Low Disease Activity in Psoriatic Arthritis? Principal Component Analysis of an International Study
    Coates, Laura
    Robinson, Danielle
    Orbai, Ana-Maria
    Kiltz, Uta
    Leung, Ying-Ying
    Palominos, Penelope
    Canete, Juan
    Scrivo, Rossana
    Balanescu, Andra
    Dernis, Emmanuelle
    Talli, Sandra
    Ruyssen-Witrand, Adeline
    Eder, Lihi
    de Wit, Maarten
    Smolen, Josef
    Lubrano, Ennio
    Gossec, Laure
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [34] Tapering and Discontinuation of Biologics in Patients with Psoriatic Arthritis with Low Disease Activity
    Weiyu Ye
    Laura J. Tucker
    Laura C. Coates
    Drugs, 2018, 78 : 1705 - 1715
  • [35] Tapering and Discontinuation of Biologics in Patients with Psoriatic Arthritis with Low Disease Activity
    Ye, Weiyu
    Tucker, Laura J.
    Coates, Laura C.
    DRUGS, 2018, 78 (16) : 1705 - 1715
  • [36] CHARACTERISATION OF DIFFERENT LOW DISEASE ACTIVITY MEASUREMENTS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Coates, L. C.
    Gottlieb, A. B.
    Merola, J. F.
    Aikman, L.
    Szumski, A.
    Chhabra, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 947 - 948
  • [37] Achievement of Sustained Remission and Low Disease Activity with Secukinumab Improves Quality of Life and Physical Function in Patients with Psoriatic Arthritis: Results from a Randomized Phase 3 Study
    Coates, Laura
    Mease, Philip
    Gladman, Dafna
    Navarra, Sandra
    Bao, Weibin
    Gaillez, Corine
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [38] SECUKINUMAB IMPROVES PHYSICAL FUNCTION AND INHIBITS STRUCTURAL DAMAGE IN PSORIATIC ARTHRITIS PSA PATIENTS WITH SUSTAINED REMISSION OR LOW DISEASE ACTIVITY: RESULTS FROM A PHASE 3 STUDY
    Coates, Laura C.
    Mease, Philip J.
    Gladman, Dafna D.
    Navarra, Sandra
    Bao, Weibin
    Gaillez, Corine
    RHEUMATOLOGY, 2022, 61
  • [39] IMMUNOGENICITY OF ANTI-TNF ANTAGONISTS IN PATIENTS WITH RHEUMATOID ARTHRITIS OR POLYARTICULAR PSORIATIC ARTHRITIS IN CLINICAL REMISSION OR LOW DISEASE ACTIVITY: THE INMUNOREMAR STUDY
    Sanmarti, R.
    Inciarte, J.
    Estrada Alarcon, P.
    Garcia Manrique, M.
    Gonzalez Navarro, A.
    Narvaez, J.
    Rodriguez-Moreno, J.
    Gomez-Centeno, A.
    Yaguee, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 479 - 479
  • [40] Good clinimetric alignment between remission and a low impact of disease in patients with axial psoriatic arthritis
    Queiro, R.
    Canete, J. D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (01) : 136 - 139
12345